Growing Old or Growing Wise with Digital Transformation?
In the first episode, Erasmus Holm, Chief Marketing Officer* for MSD in the Nordics & Baltics, is interviewing Paul Simms, Chief Executive of Impatient Health, about the buzz, the barriers, the opportunities and whether Digital Transformation can help reshape the pharma industry in the Nordics & Baltics.
What is digital transformation and what does it look like for the pharmaceutical industry? Is digital transformation the same as innovation? What does the pharmaceutical industry look like in 5-10 years? These are some of the questions Paul Simms offers his point of view on in this episode. Watch to learn!
*Since recording, Erasmus Holm has moved to a role in MSD in the Netherlands.
How to Foster Greater Patient Diversity?
In this episode, Catherine Williams, Managing Director* for MSD in Denmark & Iceland, is talking to Phaedria St.Hilaire, President of ProWoc, and Peter Drøidal, Country Manager of Novartis in Denmark & Iceland about pharma’s fast evolving social mandate to secure equity in health care in the Nordics & Baltics.
What are the barriers to securing equity and diversity in health care? What is the responsibility of the pharmaceutical industry? These are some of the questions Phaedria St.Hilaire and Peter Drøidal offer their point of view on in this episode. Watch to learn!
Can health literacy help the population make better health decisions?
In this episode, Hans Petter Strifeldt, Policy Director for MSD in the Nordics & Baltics, is talking to Kristine Sørensen, global health literacy expert, about how health literacy can help the population make better health decisions.
With an increasing need for self-care, how can health literacy help the population make better health decisions? Do the population have access to the information they need to make good decisions? And what is the pharmaceutical industry’s obligation to help people understand medical information? These are some of the questions Kristine Sørensen is answering in this episode. Watch to learn!
What does it take to implement data-driven, outcomes-based health care?
In this episode, Julie Willingham, Regional Market Access Lead for MSD in the Nordics & Baltics, is talking to Annika Szabo Portela, Managing Director of EIT Health Scandinavia, about how to advance High Value Care and what is needed to succeed in the implementation of data-driven, outcomes-based care.
What is High Value Care and what does it take to deliver outcomes-based health services? What are the obstacles to optimal sharing of health data? What should the role of the pharmaceutical industry be in this? These are some of the questions Julie Willingham and Annika Szabo Portela are discussing in this episode. Watch to learn about the importance of High Value Care.
Why are cross-discipline partnerships in the healthcare sector important?
In this episode, Umair Aslam, Business Unit Lead for MSD in Norway, is talking to Thomas Langø, Chief Researcher at SINTEF, about the importance of cross-discipline partnerships in the healthcare sector.
Over recent years, the health care ecosystem in the Nordics & Baltics has experienced significant changes, especially driven by the COVID-19 pandemic. While we have access to highly educated healthcare professionals and universal healthcare coverage, we also see a growing burden of disease, a rise in healthcare costs, evolving health needs, increasing expectations and stronger emphasis on affordable and high-quality care.
In this context, many of the key stakeholders are turning to partnerships to leverage opportunities, address challenges and inefficiencies, and access new capabilities.
Why are partnerships more important than ever? What is needed to succeed with cross-discipline partnerships? What value does the pharmaceutical industry bring to partnerships? These are some of the questions Umair Aslam and Thomas Langø are discussing in this episode. Watch to learn about the importance of partnerships.